Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.37	11.35	12.98	19.47	105.83	18.08
Short-Term Investments	62.72	64.33	110.22	61.78	-	-
Cash & Short-Term Investments	76.09	75.68	123.2	81.25	105.83	18.08
Cash Growth	-30.83%	-38.57%	51.63%	-23.23%	485.39%	48.93%
Accounts Receivable	31.11	40.8	38.06	29.2	18.57	14.49
Other Receivables	0.6	0.6	1.1	0.4	-	-
Receivables	31.71	41.4	39.16	29.6	18.57	14.49
Inventory	37.94	39.26	29.25	19.33	10.56	7.82
Prepaid Expenses	3.7	5.07	6.75	3.22	3.01	0.59
Total Current Assets	149.44	161.4	198.36	133.4	137.97	40.98
Property, Plant & Equipment	35.37	34.4	31.56	25.48	2.85	0.83
Goodwill	12.82	12.82	12.82	-	-	-
Other Intangible Assets	7.84	8.08	9.03	-	-	-
Other Long-Term Assets	0.39	0.41	0.15	0.15	-	-
Total Assets	205.85	217.09	251.91	159.02	140.82	41.81
Accounts Payable	13.22	10.52	11.84	8.67	4.06	2.27
Accrued Expenses	17.73	21.77	25.43	21.24	14.15	7.54
Current Portion of Long-Term Debt	-	-	-	-	-	1.79
Current Portion of Leases	2.03	0.41	1.4	0.34	-	-
Other Current Liabilities	0.15	2.22	6.37	-	-	-
Total Current Liabilities	33.18	34.93	45.03	30.25	18.21	11.6
Long-Term Debt	53.38	53.31	53.01	52.71	29.54	29.43
Long-Term Leases	13.91	15.93	15.89	15.54	-	-
Other Long-Term Liabilities	0.04	0.04	0.04	-	-	-
Total Liabilities	100.51	104.2	113.97	98.5	47.75	41.03
Common Stock	0.06	0.06	0.06	0.06	0.05	0.03
Additional Paid-In Capital	311.82	303	271.97	145.22	134.93	14.17
Retained Earnings	-205.91	-189.99	-134.25	-84.72	-41.91	-21.35
Treasury Stock	-0.68	-0.28	-0.01	-	-	-
Comprehensive Income & Other	0.06	0.1	0.16	-0.03	-	-
Total Common Equity	105.34	112.89	137.94	60.53	93.07	-7.16
Shareholders' Equity	105.34	112.89	137.94	60.53	93.07	0.78
Total Liabilities & Equity	205.85	217.09	251.91	159.02	140.82	41.81
Total Debt	69.36	69.65	70.3	68.59	29.54	31.22
Net Cash (Debt)	6.73	6.02	52.9	12.66	76.3	-13.14
Net Cash Growth	-83.14%	-88.61%	317.71%	-83.40%	-	-
Net Cash Per Share	0.11	0.10	0.87	0.23	1.58	-0.35
Filing Date Shares Outstanding	62.9	62.6	61.75	61.16	54.75	37.37
Total Common Shares Outstanding	62.89	62.36	61.75	55.63	54.18	37.37
Working Capital	116.26	126.48	153.33	103.16	119.76	29.38
Book Value Per Share	1.67	1.81	2.23	1.09	1.72	-0.19
Tangible Book Value	84.69	92	116.1	60.53	93.07	-7.16
Tangible Book Value Per Share	1.35	1.48	1.88	1.09	1.72	-0.19
Machinery	32.43	29.48	20.19	12.32	5.06	3.16
Construction In Progress	0.52	0.61	1.12	0.71	0.13	-
Leasehold Improvements	10.74	10.24	9.43	6.43	0.27	0.17

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q